Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech AI discovery

Anthropic Claude Finds ART Enzyme System

Analysis based on 8 articles · First reported Sep 23, 2026 · Last updated Sep 24, 2026

Sentiment
25
Attention
4
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The announcement reinforces the narrative that AI can accelerate basic scientific research, likely lifting sentiment toward AI and gene-editing related equities while raising competitive pressure on traditional biotech R&D pipelines. Concrete market effects remain limited because the finding is preliminary, unpublished in peer-reviewed form, and of unknown function.

biotechnology artificial intelligence pharmaceuticals

Anthropic unveiled the first discovery from its molecular biology lab: a previously unknown enzyme system, dubbed ART, identified by its Claude AI model. According to the company, roughly 950 Claude-powered software agents combed a DNA sequence database for 21 hours, finding more than 200,000 genes for one enzyme type and selecting 20 for closer review, work Anthropic says would take an expert scientist weeks or months. One agent spotted short repeating DNA fragments in bacteria-infecting viruses next to genes for a known enzyme and a mystery protein, a setup resembling CRISPR. Anthropic chief Dario Amodei cited the finding in video remarks to the United Nations Security Council, calling it preliminary but potentially a new gene editing mechanism with gene therapy applications. The results were published as a preprint and have not been peer reviewed. Feng Zhanwen, a CRISPR pioneer and professor at the Massachusetts Institute of Technology and the Broad Institute, called the identification genuinely intriguing and said it merits further investigation. Amodei also said a Stanford University team independently described a comparable but distinct system. Anthropic said its lab team, formed in the spring and based in the San Francisco Bay Area, does not handle pathogens capable of infecting humans, and all experiments are carried out by human scientists.

95 Anthropic unveiled enzyme discovery
70 Anthropic deployed software agents
60 Dario Amodei addressed Security Council United Nations Security Council
30 Feng Zhanwen called identification intriguing
priv
Anthropic is the central actor, unveiling its first molecular biology lab discovery and touting it as proof AI can speed basic research. The result boosts its reputation and competitive standing in AI-driven science, though the preliminary, unreviewed nature limits near-term commercial effect.
Importance 100.0 Sentiment 35.0
per
Anthropic chief executive who cited the discovery in remarks to the United Nations Security Council and predicted profound near-future progress on long-standing diseases. His dual stance of warning about AI risks while promoting AI-driven breakthroughs shapes the company's public positioning.
Importance 70.0 Sentiment 20.0
per
CRISPR pioneer and professor at the Massachusetts Institute of Technology and the Broad Institute who called the identification of the repeated DNA fragments genuinely intriguing and said it merits further investigation, lending scientific credibility to the finding.
Importance 40.0 Sentiment 10.0
alliance
Venue where Dario Amodei addressed the discovery by video link, giving the finding a high-profile international policy platform.
Importance 30.0 Sentiment 0.0
cnt
Home country of Anthropic, Stanford University, the Massachusetts Institute of Technology, and the Broad Institute, reinforcing US leadership in AI and biotechnology research.
Importance 25.0 Sentiment 10.0
ngo
Affiliation of Feng Zhanwen, whose cautious endorsement of the ART system lends credibility to the finding.
Importance 20.0 Sentiment 5.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.